Article
In vivo gene immunotherapy for cancer
9 Nov 2022
Abstract excerpt
Cancer is becoming increasingly understood not only as a disease of pathological cells but also as one of immune hypofunction. The heterogenous and patient-specific nature of cancer further underscores the need for personalized cellular therapies, which are currently produced ex vivo. Gene-modulating approaches, such as therapeutic RNAs and improved viral vectors, now bring us closer toward strategies for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
